ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0460

The Impact of Early and Artificial Menopause on Dementia Risk Among Women with Rheumatoid Arthritis

Ryan Salama1, Cassondra Hulshizer2, Cynthia Crowson3 and Elena myasoedova1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, 3Mayo Clinic, Stewartvillle, MN

Meeting: ACR Convergence 2025

Keywords: Epidemiology, Oncology, rheumatoid arthritis, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0430–0469) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Alzheimer’s disease and related dementias present an increasing global health concern, with increasing incidence and prevalence. Hormonal fluctuations associated with menopause may exacerbate inflammatory and cerebrovascular changes, contributing to neurocognitive decline. Early and artificial menopause have been linked to elevated dementia risk and neurocognitive decline in the general population. Rheumatoid arthritis (RA) has been separately established as a risk factor for dementia. However, the specific relationship between menopause characteristics and dementia in populations with RA remains unclear. We aimed to evaluate the association between artificial and early menopause on occurrence of dementia in a population with RA.

Methods: This retrospective population-based study included women /=50 years of age with incident RA in 1980-2014 who met 1987 ACR criteria and had no previous diagnosis of dementia. Age at menopause was categorically defined as the age bracket of an individual (< 45, 45–54, and ≥55 years) at 6 months post-menstruation cessation for natural cases or at the time menopause was induced for artificial cases. Menopause data was manually collected from medical records. Women with unknown age at menopause were assigned to the 45-54 age bracket; women with unknown causes of menopause were classified as natural. Artificial menopause included those with bilateral oophorectomy or chemotherapy-induced menopause. Dementia was defined as two relevant ICD-9/ICD-10 codes at least 30 days apart. Cox proportional hazards models were used to estimate the adjusted hazard ratio (aHR) and 95% confidence intervals (CI) between menopause and dementia. Individuals with early (< 45 years) or artificial menopause were compared to referents with natural or unknown-cause menopause at ≥45 years. Primary covariates included age and index year of RA incidence. To assess effect modification by RA severity and treatment, separate interaction models were performed examining the effects of RF/CCP positivity, erosions and/or destructive changes, severe extra-articular RA manifestations, or large joint swelling within one year.

Results: A total of 458 women were included, with a median age at RA incidence of 63.2 years. Sixty-six women had an outcome of dementia following RA diagnosis. Early and/or surgical menopause was present in 82 women (17.9%). Early or surgical menopause was associated with an increased risk of dementia (aHR 1.96; CI 0.99-3.89). Results were similar when adjusting for RF/CCP positivity, obesity, smoking, and education. For the interaction analyses, no statistically significant effect modifications were observed (all interactions P >0.05).

Conclusion: In women with RA, early or surgical menopause was associated with a nearly two-fold increase in risk of dementia, suggesting the need for increased awareness of increased risk for cognitive decline in this population of patients with RA. This association was not significantly modified by RA severity factors, smoking, education, or obesity.


Disclosures: R. Salama: None; C. Hulshizer: None; C. Crowson: None; E. myasoedova: None.

To cite this abstract in AMA style:

Salama R, Hulshizer C, Crowson C, myasoedova E. The Impact of Early and Artificial Menopause on Dementia Risk Among Women with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-impact-of-early-and-artificial-menopause-on-dementia-risk-among-women-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-early-and-artificial-menopause-on-dementia-risk-among-women-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology